Johnson & Johnson Is Maintained at Outperform by RBC Capital
Johnson & Johnson Analyst Ratings
RBC Capital Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Raises Target Price to $178
Goldman Sachs Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Raises Target Price to $162
DBS Maintains Johnson & Johnson(JNJ.US) With Hold Rating
Wells Fargo Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $163
Wells Fargo Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $163
Johnson & Johnson Price Target Maintained With a $215.00/Share by Cantor Fitzgerald
Johnson & Johnson Analyst Ratings
Cantor Fitzgerald Remains a Buy on Johnson & Johnson (JNJ)
Johnson & Johnson Analyst Ratings
RBC Capital Reiterates Outperform on Johnson & Johnson, Maintains $175 Price Target
RBC Capital Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $175
Johnson & Johnson (JNJ) Gets a Buy From RBC Capital
Johnson & Johnson Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Johnson & Johnson, Maintains $215 Price Target
Cantor Fitzgerald Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $215
Citi Maintains Johnson & Johnson(JNJ.US) With Buy Rating
Johnson & Johnson Analyst Ratings
Wells Fargo Maintains Johnson & Johnson(JNJ.US) With Hold Rating